AChE/BACE1/GSK3β-IN-1

Overview

AChE/BACE1/GSK3β-IN-1 is an orally active triple inhibitor of AChE/BACE1/GSK3β . AChE/BACE1/GSK3β-IN-1 has effective inhibitory activity against AChE , BACE1 and GSK3β with IC 50 values of 1.0 μM, 20 μM and 15 μM, respectively. AChE/BACE1/GSK3β-IN-1 has good blood-brain barrier penetrability, suitable bioavailability. AChE/BACE1/GSK3β-IN-1 can be used for the research of Alzheimer's disease (AD).

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Stem Cell/Wnt | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Beta-secretase | Products > Signaling Pathways > Cholinesterase (ChE) | Products > Signaling Pathways > GSK-3

Product Information

• Catalog No.: HY-151260
• CAS No.: 2866066-81-9
• Molecular Formula: C26H27FN2O4
• Molecular Weight: 450.50
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source